Search

Michelle L Matter

from San Diego, CA
Age ~46
Get Report
Also known as:
Michelle Lee Pansoy, Michelle L Bellis, Michelle L Pansoy, Pansoy Michelle Bellis, Michelle L Bellispansoy, Michelle L Bellis-Pansoy, Michelle Ellis
Related to:
Eliana Chavez Davis, 35Jacquelyn M Matter, 29Gerald Bellis, 48Nicole Jordan, 44Michael S Huffman, 66Joshua G Jordan, 43Steven J Bellis, 46Leia R Bellis, 45Douglas William Matter, 71Debra D Matter, 71Brian W Matter, 45Christopher R Matter, 46
Connected to:
Anthony Matter, 54Aumori A Matter, 38Brittany Matter, 32Carl M Mattera, 62Carla J Matter, 75Christine Mattera, 78Christopher Matter, 50Cynthia L Mattera, 65Cyril W Matter, 81Dawn R Matter, 76

Michelle Matter Phones & Addresses

  • San Diego, CA
  • Chula Vista, CA
  • El Cajon, CA
  • 860 Piccard Ave, San Diego, CA 92154

Work

Company: Elderhelp of san diego Jul 2019 Position: Special projects director

Education

Degree: Master of Business Administration, Masters School / High School: Louisiana State University 2020 to 2021

Skills

Community Outreach • Public Speaking • Nonprofits • Event Planning • Public Policy • Leadership • Public Relations • Program Development • Fundraising • Community Development • Volunteer Management • Media Relations • Strategic Communications • Grant Writing • Speech Writing • Policy • Leadership Development

Industries

Non-Profit Organization Management

Resumes

Resumes

Michelle Matter Photo 1

Special Projects Director

View page
Location:
San Diego, CA
Industry:
Non-Profit Organization Management
Work:
Elderhelp of San Diego
Special Projects Director
Girl Scouts San Diego Apr 2017 - May 2018
Volunteer Relations - Conflict Management
Serving Seniors Jan 2016 - Dec 2016
Director of Communications and External Affairs
Bridgepoint Education Sep 2010 - Dec 2015
Manager of Government Affairs
Centre City Development Corporation Sep 2008 - Sep 2010
Communications Specialist
Education:
Louisiana State University 2020 - 2021
Master of Business Administration, Masters University of Southern California 2018
Doctorates, Doctor of Education, Leadership, Education University of Southern California
Masters
Skills:
Community Outreach
Public Speaking
Nonprofits
Event Planning
Public Policy
Leadership
Public Relations
Program Development
Fundraising
Community Development
Volunteer Management
Media Relations
Strategic Communications
Grant Writing
Speech Writing
Policy
Leadership Development

Publications

Us Patents

Methods Of Modulating Cell Death Based On The Bit1/Aes Regulatory Pathway

View page
US Patent:
7393653, Jul 1, 2008
Filed:
Sep 5, 2003
Appl. No.:
10/655755
Inventors:
Yiwen Jan - San Diego CA, US
Michelle Matter - Martinsville NJ, US
Erkki Ruoslahti - Rancho Santa Fe CA, US
Assignee:
The Burnham Institute - La Jolla CA
International Classification:
G01N 33/53
G01N 33/567
G01N 33/574
C12P 21/02
US Classification:
435 72, 435 721, 435 723, 435 795, 435 697, 435 698, 43525233
Abstract:
The present invention provides a method of identifying an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. The method is practiced by contacting a Bit1 polypeptide, or active fragment thereof, and an AES polypeptide, or active fragment thereof, with an agent under conditions that allow the Bit1 polypeptide or active fragment thereof to associate with the AES polypeptide or active fragment thereof; and detecting an altered association of the Bit1 polypeptide or active fragment thereof and the AES polypeptide or active fragment thereof, where an altered association indicates that the agent is an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. Such an effective agent can modulate apoptosis and can be a useful therapeutic agent.

Methods Of Modulating Cell Death Based On The Bit-1/Aes Regulatory Pathway

View page
US Patent:
8017326, Sep 13, 2011
Filed:
Jun 6, 2008
Appl. No.:
12/135068
Inventors:
Yiwen Jan - San Diego CA, US
Michelle Matter - Martinsville NJ, US
Erkki Ruoslahti - San Diego CA, US
Assignee:
Sanford-Burnham Medical Research Institute - La Jolla CA
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides a method of identifying an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. The method is practiced by contacting a Bit1 polypeptide, or active fragment thereof, and an AES polypeptide, or active fragment thereof, with an agent under conditions that allow the Bit1 polypeptide or active fragment thereof to associate with the AES polypeptide or active fragment thereof; and detecting an altered association of the Bit1 polypeptide or active fragment thereof and the AES polypeptide or active fragment thereof, where an altered association indicates that the agent is an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. Such an effective agent can modulate apoptosis and can be a useful therapeutic agent.

Methods Of Modulating Cell Death Based On The Bit1/Aes Regulatory Pathway

View page
US Patent:
20120014974, Jan 19, 2012
Filed:
Jun 6, 2011
Appl. No.:
13/154327
Inventors:
Yiwen Jan - San Diego CA, US
Michelle Matter - Martinsville NJ, US
Erkki Ruoslahti - Rancho Santa Fe CA, US
Assignee:
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE - La Jolla CA
International Classification:
A61K 39/395
C12Q 1/48
A61K 31/7052
A61P 25/16
A61P 25/28
A61P 9/10
A61P 27/02
A61P 7/06
C12Q 1/02
A61K 38/02
US Classification:
4241781, 435 29, 435 15, 514 43, 514 11, 514 178, 514 164, 514 208
Abstract:
The present invention provides a method of identifying an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. The method is practiced by contacting a Bit1 polypeptide, or active fragment thereof, and an AES polypeptide, or active fragment thereof, with an agent under conditions that allow the Bit1 polypeptide or active fragment thereof to associate with the AES polypeptide or active fragment thereof; and detecting an altered association of the Bit1 polypeptide or active fragment thereof and the AES polypeptide or active fragment thereof, where an altered association indicates that the agent is an effective agent that alters the association of a Bit1 polypeptide with an AES polypeptide. Such an effective agent can modulate apoptosis and can be a useful therapeutic agent.
Control profile
Michelle L Matter from San Diego, CA, age ~46 Get Report